AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...

Analysts have been eager to weigh in on the Financial sector with new ratings on JPMorgan Chase & Co. (JPM – Research Report), Bank of New ...

The bank said profit rose 50% to $14 billion in the fourth quarter as noninterest expenses fell 7% from a year earlier.

JPMorgan Chase & Co.'s Chief Executive Jamie Dimon told analysts on Wednesday he plans to stay in the job "for a few more ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

The bank, which owns a minority stake in Viva Wallet, can take over the company in June if its valuation falls before a ...

Global brokerage JP Morgan believes that both Swiggy and Zomato are available at attractive prices for taking positions in ...

Jamie Dimon said there is a running list of executives who could replace him as CEO of JPMorgan. The comments follow the ...

Bruce Cozadd, the retiring CEO of Jazz Pharmaceuticals, has outlined a developing oncology pipeline at the company. Speaking ...

Recoveries will need to come from how Indian courts rule on the company's broader insolvency plan and how it aims to repay ...

The only danger, from Wall Street’s perspective, is that the Trump team’s MAGA instincts and chaotic approach prevent a ...

There’s a lesson here for long-term leaders: When the time comes, let go. James Gorman at Morgan Stanley has definitely ...